According to IMARC Group’s latest report, titled “Natural Killer Cells Therapeutics Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027”, the global natural killer cells therapeutics market reached a value of US$ 2.1 Billion in 2021. Natural killer (NK) cell therapeutics is a kind of cellular immunotherapy that uses lymphocytes as a medicinal agent for the treatment of various pathological challenges. They contain unique proteins, such as proteases and perforin or granzymes. NK cells approach and target foreign cells by releasing protein, which generates an immune system response in cases of viral infections and malignancies. They also help reduce the risk of cytokine storms and can be acquired from a variety of sources, thus eliminating the need for patient-specific immune cells.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample
The increasing prevalence of various chronic disorders, such as cancer, infections, and liver diseases, and the growing demand for molecular and combinational therapies are some of the prime factors currently driving the global natural killer cell therapies market growth. Additionally, the introduction of the ex vivo pre-conditioning approach and small molecular medications to enhance their therapeutic potential is propelling the market growth. Apart from this, significant improvements in the healthcare infrastructure and the ongoing research and development (R&D) activities to engineer bi-specific antibodies are contributing to the market growth. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 15.65% during 2022-2027.
Competitive Landscape with Key Players:
- Affimed GmbH
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Fortress Biotech Inc.
- Glycostem Therapeutics
- Innate Pharma S.A.
- Kuur Therapeutics Inc
- Athenex Inc
- Nkarta Inc.
- Takeda Pharmaceutical Company Limited
- Ziopharm Oncology Inc.
Breakup by Therapeutics:
- NK Cell Therapies
- NK Cell Directed Antibodies
Breakup by Application:
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
Breakup by End User:
- Hospitals
- Research Centers and Institutes
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
